{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04632953",
            "orgStudyIdInfo": {
                "id": "UX007-CL401"
            },
            "organization": {
                "fullName": "Ultragenyx Pharmaceutical Inc",
                "class": "INDUSTRY"
            },
            "briefTitle": "Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program",
            "officialTitle": "Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program (LC-FAOD DMP)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "long-chain-fatty-acid-oxidation-disorders-in-clinic-disease-monitoring-program"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-11-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2035-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2035-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-11-09",
            "studyFirstSubmitQcDate": "2020-11-16",
            "studyFirstPostDateStruct": {
                "date": "2020-11-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Ultragenyx Pharmaceutical Inc",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of this study is to assess the long-term safety, including pregnancy, infant, and lactation outcomes, of patients with LC-FAOD who are enrolled in the DMP.",
            "detailedDescription": "The LC-FAOD DMP is a global observational long-term prospective outcomes study aiming to collect information for up to 10 years from adult and pediatric patients with LC-FAOD, regardless of disease management, including treatment with triheptanoin, and those who have previously participated in triheptanoin clinical trials or Expanded Access Program (EAP).\n\nPatients enrolling in the LC-FAOD DMP will be managed at the discretion of their physicians and may or may not be treated with triheptanoin during the course of the study. Patients will only have access to triheptanoin through authorized commercial use (if approved in their country) or available EAP but not from the LC-FAOD DMP itself."
        },
        "conditionsModule": {
            "conditions": [
                "Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)"
            ],
            "keywords": [
                "CACT Deficiency",
                "Carnitine Acylcarnitine Translocase Deficiency",
                "CPT1",
                "CPT2",
                "Carnitine Palmitoyltransferase Deficiencies",
                "VLCAD",
                "Very Long Chain Acyl Coa Dehydrogenase Deficiency",
                "LCHAD Deficiency",
                "Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency",
                "TFP Deficiency",
                "Trifunctional Protein Deficiency"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Previously Treated with Triheptanoin",
                    "description": "Patients who have been previously treated with triheptanoin in clinical studies: UX007-CL201 (NCT01886378), UX007-CL202 (NCT02214160), UX007-CL302 (2022-001539-10), Investigator Sponsored Trials (ISTs), or UX007-EAP (NCT03773770).",
                    "interventionNames": [
                        "Other: No Intervention"
                    ]
                },
                {
                    "label": "Currently Treated with Triheptanoin",
                    "description": "New patients enrolling into the DMP currently being treated with triheptanoin (excluding those in the previously treated with triheptanoin cohort).",
                    "interventionNames": [
                        "Other: No Intervention"
                    ]
                },
                {
                    "label": "Triheptanoin Na\u00efve",
                    "description": "New patients enrolling into the DMP with no exposure to triheptanoin.",
                    "interventionNames": [
                        "Other: No Intervention"
                    ]
                },
                {
                    "label": "Triheptanoin Na\u00efve Transitioned to Triheptanoin",
                    "description": "Patients already enrolled into the triheptanoin na\u00efve cohort but transition to triheptanoin during the DMP after enrollment.",
                    "interventionNames": [
                        "Other: No Intervention"
                    ]
                },
                {
                    "label": "Pregnant unaffected LC-FAOD carrier females",
                    "description": "Pregnant, unaffected (women who do not have the mutations causing LC-FAOD) LC-FAOD carrier females, carrying a fetus with a diagnosis of LC-FAOD confirmed via prenatal testing.",
                    "interventionNames": [
                        "Other: No Intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "No Intervention",
                    "description": "No Intervention",
                    "armGroupLabels": [
                        "Currently Treated with Triheptanoin",
                        "Pregnant unaffected LC-FAOD carrier females",
                        "Previously Treated with Triheptanoin",
                        "Triheptanoin Na\u00efve",
                        "Triheptanoin Na\u00efve Transitioned to Triheptanoin"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Long-Term Safety of Patients with LC-FAOD as Assessed by Incidence of Serious Adverse Events (SAEs) and Adverse Events (AEs) During Pregnancy for all Patients with LC-FAOD",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-Term Safety of Patients with LC-FAOD as Assessed by Neonate and Infant Outcomes from Pregnancy Throughout the First Year of Life",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-Term Safety of Patients with LC-FAOD as Assessed by Incidence of SAEs Assessed as Related to Triheptanoin Treatment by Study Investigator",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-Term Safety of Patients with LC-FAOD as Assessed by Incidence of all Colon Cancer or Gastrointestinal (GI) Cancer, GI Dysplasia, and GI Neoplasia, SAE's and AEs Reported for all Patients with LC-FAOD",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-Term Safety of Patients with LC-FAOD as Assessed by Incidence of all SAEs and AEs in Nursing Mothers and Their Breast-Milk-Fed Infants",
                    "timeFrame": "10 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Long-term Effectiveness of Triheptanoin in Patients with LC-FAOD as Assessed by Major Clinical Events (MCEs)",
                    "description": "Number and duration of MCEs, including rhabdomyolysis, cardiomyopathy, liver damage, and hypoglycemia",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-term Effectiveness of Triheptanoin in Patients with LC-FAOD as Assessed by Hospitalizations",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-term Effectiveness of Triheptanoin in Patients with LC-FAOD as Assessed by Mortality",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-term Effectiveness of Triheptanoin in Patients with LC-FAOD as Assessed by 12-Minute Walk Test (12MWT)",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-term Effectiveness of Triheptanoin in Patients with LC-FAOD as Assessed by Time to First MCE in Newborns and Pediatrics",
                    "timeFrame": "10 Years"
                },
                {
                    "measure": "Long-term Effectiveness of Triheptanoin in Patients with LC-FAOD as Assessed by Height/Recumbent Length",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-term Effectiveness of Triheptanoin in Patients with LC-FAOD as Assessed by Weight",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Long-term Effectiveness of Triheptanoin in Patients with LC-FAOD as Assessed by Head Circumference",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by the Infant and Toddler Quality of Life (ITQOL)",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by the Medical Outcomes Study 10-Item Short Form (SF-10)",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by the Medical Outcomes Study 12-Item Short Form (SF-12 v2) assessments",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by the Clinical Global Impression of Severity (CGI-S) assessment",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by Nutrition Management and Dosing",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by Medical Resource Utilization",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by LC-FAOD Symptoms and Impact",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by the Work Productivity Questionnaire",
                    "timeFrame": "10 years"
                },
                {
                    "measure": "Natural History, Progression, and Burden of LC-FAOD from the Patient/Caregiver's Perspective as Assessed by the School Impact Questionnaire",
                    "timeFrame": "10 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Confirmed diagnosis of any LC-FAOD sub-type. Diagnosis must be confirmed by results of acylcarnitine profiles, and/or genetic testing results obtained from medical records or equivalent documentation.\n* Willing and able to comply with all study procedures.\n* Willing and able to provide consent or, if a minor, provide assent and informed consent by their legally authorized representative.\n* Female of child-bearing potential who become pregnant during the study will be invited to remain in the study. Pregnant females with LC-FAOD will be informed of the study and invited to enroll.\n* Pregnant females not affected by LC-FAOD carrying a fetus affected by LC-FAOD with confirmed pre-natal diagnosis of LC-FAOD.\n\nExclusion Criteria:\n\n* Presence of a concurrent disease or condition that would interfere with study participation or affect patient's safety in the opinion of the Investigator.\n* Presence or history of any condition that, in the view of the Investigator, places the patient at high risk of not completing the study or would affect the interpretation of study results.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Approximately 200 patients, either treated or untreated with triheptanoin, will be enrolled for this study.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Patients Contact: Trial Recruitment",
                    "role": "CONTACT",
                    "phone": "1-888-756-8657",
                    "email": "trialrecruitment@ultragenyx.com"
                },
                {
                    "name": "HCPs Contact: Medical Information",
                    "role": "CONTACT",
                    "phone": "1-888-756-8657",
                    "email": "medinfo@ultragenyx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Ultragenyx Pharmaceutical Inc",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Phoenix Children's Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "University of California San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94158",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Children's Hospital of Colorado",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "University of South Florida",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33606",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "The Emory Clinic",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Ann & Robert H. Lurie Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Boston Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55454",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                },
                {
                    "facility": "Columbia University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Nationwide Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43205",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Children's Hospital of Pittsburgh of UPMC",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15224",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "University of Utah",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84108",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "Seattle Children's Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98020",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "University of Alberta",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 1C9",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "CHEO (Children's Hospital Eastern Ontario)",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Ottawa",
                    "state": "Ontario",
                    "zip": "K1H 8L1",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.41117,
                        "lon": -75.69812
                    }
                },
                {
                    "facility": "SickKids (The Hospital for Sick Children)",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 1X8",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Ultragenyx Patient Advocacy/LC-FAOD Disease Information",
                    "url": "https://ultrarareadvocacy.com/conditions-we-study/long-chain-fatty-acid-oxidation-disorders-lc-faod/"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M14351",
                    "name": "Protein Deficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "T3332",
                    "name": "LCAD Deficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "T5872",
                    "name": "VLCAD Deficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "T3333",
                    "name": "LCHAD Deficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "T3848",
                    "name": "Mitochondrial Trifunctional Protein Deficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "T978",
                    "name": "Carnitine-acylcarnitine Translocase Deficiency",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "T372",
                    "name": "Carnitine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}